Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think it's most likely share exchange ...like X amount of amda's shares will be exchanged per 1 ZHB' share...IMO.
Or partial cash + partial share exchange.
X = ??? <<< Only god knows...lmao.
4. Strategic Fit with Buyer. The buyer is concerned not only with the likely future performance of the target company as a stand-alone business; it will also want to understand the extent to which the company will fit strategically within the larger buyer organization. Related questions and areas of inquiry will include the following:
Will there be a strategic fit between the company and the buyer, and is the perception of that fit based on a historical business relationship or merely on unproven future expectations?
Does the company provide products, services, or technology the buyer doesn’t have?
Will the company provide key people (is this an acqui-hire?) and if so what is the likelihood of their retention following the closing?
What integration will be necessary, how long will the process take, and how much will it cost?
What cost savings and other synergies will be obtainable after the acquisition?
What marginal costs (e.g., costs of obtaining third party consents) might be generated by the acquisition?
What revenue enhancements will occur after the acquisition?
https://www.forbes.com/sites/allbusiness/2014/12/19/20-key-due-diligence-activities-in-a-merger-and-acquisition-transaction/#228b0a114bfc
This website says it all...lmao...
Also, do you have link to videos, presentations, graphical descriptions about CSC vs. traditional spine surgery does required 2nd site bone graft from patients' own body?
I m not sure man...I hope we have long investors that can read chinese & search on Baidu, China search engine & do DDs on that.
Also, what I was trying to say in the last post about AMDA is the bridge...it means contract pending CFDA with Weigao already helps Zimmer to pull in future revenue post acquisition...IMO.
220K+ units X 1000 = $200+ millions man...lmao.
This is just valeo only...not even talking about future revenue of other products.
AMDA is the bridge between Zimmer & Weigao in china...Weigao DIVORCED Medtronics (giant in EU that controls market of the inferior biomaterial PEEK) years ago.
You can see clearly Si3N4 is stepping on many giants' toes!
Sleeping with 1 giant (Zimmer) is like giving middle finger to other giants in the Ortho Sectors! Hence the hidden attack for years!
IMO...as soon as they get the si3n4 hip product approved later (post acquisition)...they will cut lose this middle man (Ceramtec Germany) for their hip revenue:
http://www.zimmer.com/content/dam/zimmer-web/documents/en-US/pdf/surgical-techniques/hip/zimmer-maxera-cup-surgical-technique.pdf
Their recent colab with Zimmer to test the hip fermol head...the result surely beat all these current hip replacement set up on the market, even the best COC (crack, fracture & noisy) has no match:
http://imgur.com/a/9NMei
Strykers & Zimmer are currently fighting hard to control the market in ASIA! It makes si3n4 even more valuable to Zimmer.
http://www.idataresearch.com/zimmer-biomet-stryker-lead-billion-dollar-asia-pacific-hip-knee-implant-market-due-increase-viable-patient-population/
“The fastest growing market by country is Japan due their significant number of elderly patients,” explains Dr. Kamran Zamanian, CEO of iData. “While total population is slow to grow in Japan, the roughly 60+ demographic, which represents the age category most at risk of osteoarthritis, is rising quickly.”
In their 8K:
"With recent submission of favorable clinical data to the Japan PMDA, the company expects approval in that market as well."
Tested this Japan:
http://www.amedica.com/news-media/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
Acquiring Amda will sure own the market in China..China giant Weigao deal:
http://imgur.com/a/eKZ2N
https://www.forbes.com/sites/allbusiness/2014/12/19/20-key-due-diligence-activities-in-a-merger-and-acquisition-transaction/#340d989f4bfc
"4. Strategic Fit with Buyer. The buyer is concerned not only with the likely future performance of the target company as a stand-alone business; it will also want to understand the extent to which the company will fit strategically within the larger buyer organization. Related questions and areas of inquiry will include the following:"
Don't forget many other possibility usage of si3n4 too:
http://www.khq.com/story/34959158/biomaterials-market-to-reach-125152-billion-with-14-cagr-forecast-to-2020
So the valuation is crazy!
si3n4 in the hand of Zimmer...they will know how to profit from it due to their big foot print in many regions.
Do you guys see the connections between amda & zimmer ????
So they (the share price manipulators) can create another round of fake sell-off for them to maximize the profit = cover short positions cheaper & at the same time scoop up more shares from fainted hearts to profit on the BO.
BK, Dilution, RS, Delisting to OTC, blah blah...many fainted hearts rookies fall for this all the time...GTFO....sell sell sell..set stop losses for them to trigger!
Many ways for them to attack the sentimental retail investors' weak hearts.
I don't think it's the acquirer's game to attack the PPS.
The whole point they make an assault on the pps to be under .25 is to push it under $10Mils MC so they can create another listing issue for amda.
Ask the owner of these 2.3 Millions short interests!
There are 2 major scenarios that they will audit long-lived assets:
#1 BK <<<< does amda looks like they will fold (Chapter 11)? HECK NO! This happened a lot back in 2008 crash, downturn of the market...when Compound annual growth rate (CAGR) of most companies in the negative.
#2 ACQUISITION <<<< Measuring the fair value before sale/purchase of assets.
http://www.cheneliere.info/cfiles/complementaire/complementaire_gm/fichiers/certif/8410_fvtoolkit.pdf
They are in the process of producing GAAP or could be done & being reviewed by the buyer.
https://media2.mofo.com/documents/1506practicepointersonfinancialstatement.pdf
EXACTLY! The prelim 8K is to hint investors to calm down...firework is coming very soon...before August!
All debt will retire by January 2018, or sooner. Absent new financing, Amedica expects to be compliant with its debt covenants under the Hercules loan through July 2017.
I saw you updated the page. I will add more entries later.
All debt will retire by January 2018, or sooner. Absent new financing, Amedica expects to be compliant with its debt covenants under the Hercules loan through July 2017.
From the past filings, do you ever see they made that type of statement?
IMO...Amedica will be operated under the same name, but as Zimmer' subsidiary ...Just exactly like Jet.com was acquired by Walmart, but still operate as Jet.com for a special reason.
That is 2016...what about 2017??? How many dudes from Zimmer were assigned to them beside Lyons & Long?
2nd page too...lol
Also, I haven't dug into EU, Brazil & other countries.
Beside this guy:
https://www.linkedin.com/in/dana-lyons-a23b9550/
& This guy:
https://www.linkedin.com/in/ryanjlong/
Who are these VPs:
http://imgur.com/a/88ylp
10 Mils Market Cap AMDA can really afford to hire & pay them???
not necessarily man...depends on their details PR to investors...what if they say they found a priceless GEM & lay out the details how AMDA's si3n4 will help generate XXXXXXXXXX amount of revenue...remember china deal about $300 mils already.
Correct...they position themselves well...they possibly know something coming.
How do I post image on ihub...ST is real easy..but IH makes it so complicated.
At first you look at these .28 trades...it looks like one account (they stole the shares from the crash) passed shares to another account (they previous shorted position) to cover...of course all from MMs. But later it pops all the way to .317 & back down to .295 range (a couple hundred 1000s shares were stolen from happy flippers)...then they turned around fill these orders @ .33+, then the pops start there til the bells. I believe some big $$$ was buying on leak news (possibly)...ZBH'share price has been up for the past 3 weeks straight.
Blackrock added 16 mils shares on ZBH (valued almost about $2 BILLIONS!)
https://fintel.io/so/us/zbh
Blackrock also started position in amda as well
https://fintel.io/so/us/amda
In between 2 spikes of pps...300K shares were stolen from happy flippers (2 f-ing pennies gain), then they filled all the shares to .33+ orders...
Boston, I told you once that this how they these MMs rats steal!
I am here for gain per share in dollars range NOT pennies.
I hope some leaked news that triggered this kind of volume.
I still stick with my BO thesis (of course it's my view, analysis, & opinion).
Boston & I have dug very deep & pieces of info have been stitched together.
Hope there is a HALT next week.
short interests up to 5.31.2017 doesn't change much = these 2 millions shares shorted from .36 to .26 were the MMs.
click on my profile..my fav. link!!!!! register...we can talk from there..hurry!
Good find man!
SNAP results is consitent with previous observations that silicon nitride shows enhanced and earlier spine fusion than PEEK.
Modi CSC then later CSC, Dental, Knee, Japan PMDA all in the work...
IMO...all of these will be all handled by Zimmer post acquisition.
I believe audits are almost done & deal can be finalized...They hinted the debt can be paid off sooner (I would expect to be paid off before deal close).
Almost all Zimmer's Trabecular's products have recalls...crazy! Doesn't matter dental, knee, shoulder, etc...
https://www.google.com/search?q=SpF+XL+IIB+Implantable+Spinal+Fusion+Stimulators.&oq=SpF+XL+IIB+Implantable+Spinal+Fusion+Stimulators.&aqs=chrome..69i57&sourceid=chrome&ie=UTF-8#q=recalls+on+trabecular+metal
All over the internet. Amda's Si3n4 can fix all of these current issue & will bring in substantial revenue for Zimmer later too.
https://www.zacks.com/stock/news/263566/zimmer-biomet-rides-on-spine-business-knee-challenges-stay
Find my fav. links in my profile.
In collaboration with its auditors, Amedica continues to consider any potential impairment in relation to certain of its long-lived assets. Once this exercise is completed, the Company will promptly complete its Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and file it with the SEC. Upon filing of the annual report the Company also expects to promptly file its quarterly report on Form 10-Q for the first quarter ended March 31, 2017.
All debt will retire by January 2018, or sooner. Absent new financing, Amedica expects to be compliant with its debt covenants under the Hercules loan through July 2017.
Hercules loan PREVENTS take over!
The only tiny lawsuit was settled 4Q last year.
http://www.cheneliere.info/cfiles/complementaire/complementaire_gm/fichiers/certif/8410_fvtoolkit.pdf
https://www.forbes.com/sites/allbusiness/2014/12/19/20-key-due-diligence-activities-in-a-merger-and-acquisition-transaction/#1a09c6ef4bfc (esp. # 4):
4. Strategic Fit with Buyer. The buyer is concerned not only with the likely future performance of the target company as a stand-alone business; it will also want to understand the extent to which the company will fit strategically within the larger buyer organization. Related questions and areas of inquiry will include the following:
Some fool on ST tries to spin that no BO mention in the 8K...lmao ...that would be so illegal to mention until it's, the BO is finalized!
That is why it's called Due Diligence for investors to dig in and foresee the acquisition is in the making. The company can't disclose these as of now....still lmao as someone expect to read that in the 8K this morning.
I am sure Boston will try to write an article on SA. We can help to dig in more & provide more DDs to him. So he can put more info. on the article if he would write one later.
BO is in the making...the GAAP is stil in the process to be produced...they have to go back & fully audit 3 yrs with GAAP. I posted the pdf file 3 times already. Read it! It's a long process...
To be honest with you...CSC will be handled all by Zimmer post take over!
That is even a good news...in the mean time we are waiting for BO news...we won't have to worry about the negative news on CSC from FDA!!!
and this hint:
The company has reduced its total debt to approximately $4 million, down from $24.3 million in July 2015 and from $36 million in late 2014. All debt will retire by January 2018, or sooner. Absent new financing, Amedica expects to be compliant with its debt covenants under the Hercules loan through July 2017.
In collaboration with its auditors, Amedica continues to consider any potential impairment in relation to certain of its long-lived assets. Once this exercise is completed, the Company will promptly complete its Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and file it with the SEC. Upon filing of the annual report the Company also expects to promptly file its quarterly report on Form 10-Q for the first quarter ended March 31, 2017.
Love it!
End of March was $5.7 mil outstanding debt - read hercules' 1Q ER...you will see it stated in there.
April + May + June payments = $1.5 mils ($500K monthly)
So the current debt is about $4.2..is about right.
Still in the process to produce the GAAP (read the long-lived asset audit)...for this:
http://www.cheneliere.info/cfiles/complementaire/complementaire_gm/fichiers/certif/8410_fvtoolkit.pdf
I love the way they put out this prelim to shut the bears' mouth to stop the attack on amda as: R/S, BK, Dilution, Scam, etc...
Amedica reported preliminary revenue of $3.7 million for the fourth quarter of 2016 and $15.2 million for the full year. Preliminary GAAP net loss for the fourth quarter of 2016 was $0.16 per share, compared to net loss of $0.55 per share in the fourth quarter of 2015. For the full year, the company reported preliminary GAAP net loss of $1.19 per share, compared to a net loss of $5.50 per share in 2015. The company’s cash and cash equivalents were $6.9 million at December 31, 2016, a decrease of $4.6 million from December 31, 2015.
http://archive.fast-edgar.com//20170608/AM2YH22CZ22RT2MX222N2WX2QMOAZZ22Z292/
Yes..Boston was planning to write an article on SA. I think the time now is ripe for that article as all of these info. & connections show more evidences that Zimmmer is behind the acquisition deal.
Non medical application:
http://www.aerospacemanufacturinganddesign.com/article/kyocera-expands-industrial-ceramics-manufacturing-washington-042816/
http://c.eqcdn.com/_5c7526ae538a6086a4025ef13f5136d2/amedica/db/224/1039/pdf/AMDA_Investor+Presentation_Jan++2017.pdf (on the last page)
So many connections.
AMDA'S CURRENT valuation is crazy!
I am seeing 3 some relationship, esp. the recent kyocera ground breaking to expand their manufacturing process...zimmer buys amda & kyocera will make all the products for zimmer (amda's in-house can't handle production to fulfill's zimmer's sale volume)
Their 3D printing:
https://3dprint.com/tag/kyocera/
AMDA's 3d printing article:
https://3dprint.com/126023/3dp-silicon-nitride-ceramics/
https://www.thestreet.com/story/13952705/1/zimmer-puts-bribery-scandal-in-the-past.html
Zimmer has a little bad history with SEC links to bribery in Brazil & Mexico regarding acquisition. This time with AMDA, i bet they will make sure it's nice & clean take over hence the long, on going auditing.
http://www.sintexmedical.com.br/home
http://www.sintexmedical.com.br/
A big launch in Brazil...For sure AMDA's resource can't create this super launch of products. Zimmer has big foot print in Brazil.
It's so obvious that Zimmer is the buyer. While we are waiting on the BO news, these thieves will make more assault on the share price to cover these 2.3 mils shorted shares. I hope someone will put together all these info., evidences of speculating an acquisition from Zimmer. & write a seeking alpha articles for the mass to read & DDs on AMDA...That would attract tons of attention. I can't wait til Friday market closed to see the up to date short interests.
@ .22 = CASH...lmao...ridiculous. This is their last chance to make an assault AMDA I believe. Can't wait til next week man.
Form 4 @ this moment will possibly turn into an "insider trading" issue.
Time is pushing closer & closer...Friday market closed, we gonna see the short interest update...Will be fun to see the new #. Also, do you see your special friend "7948" & the gangs crawled out to bash again your long positions? Remember to take roll calls in your excel sheet.
First, assault on the pps makes it look like a sell-off, then
http://boards.fool.com/paid-stock-bashers-lp-13645949.aspx
The MMs can trade from left hands to right hands to manipulate.
Wink Wink Wink...7 more trading sessions for the assault from the hidden manipulators. Yesterday, they tried a little. Today, they tried a few times. I bet tomorrow they will try again to knock this again. Wink Wink Wink.
What I am seeing is the MMs are trying to fool the mass to help someone to buy cheap or cover shares.